CIK 0002056611 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Latigo Biotherapeutics, Inc.
Sign in to watch- Ticker
- LTGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832625838
- Phone
- 805-716-2927
- Business address
- 1300 RANCHO CONEJO BLVD., SUITE 305, THOUSAND OAKS, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-10 | 5AM Ventures VI, L.P. 10% owner | Conversion | +4,975,543 | 4,975,543 | ||
| 2026-08-10 | 5AM Ventures VI, L.P. 10% owner | Conversion | +2,350,419 | 2,350,419 | ||
| 2026-08-10 | 5AM Ventures VI, L.P. 10% owner | Conversion · Series A Preferred Stock | −3,152,305 | 0 | ||
| 2026-08-10 | 5AM Ventures VI, L.P. 10% owner | Conversion · Series A-2 Preferred Stock | −1,823,238 | 0 | ||
| 2026-08-10 | 5AM Ventures VI, L.P. 10% owner | Conversion · Series A-2 Preferred Stock | −866,018 | 0 | ||
| 2026-08-10 | 5AM Ventures VI, L.P. 10% owner | Conversion · Series B Preferred Stock | −1,484,401 | 0 | ||
| 2026-08-10 | Sanofi 10% owner | Conversion | +494,800 | 494,800 | ||
| 2026-08-10 | Sanofi 10% owner | Conversion | +177,978 | 672,788 | ||
| 2026-08-10 | Sanofi 10% owner | Conversion · Series B Preferred Stock | −494,800 | 0 | ||
| 2026-08-10 | Sanofi 10% owner | Conversion · Convertible Promissory Note | −177,978 | 0 | ||
| 2026-08-10 | Westlake BioPartners Fund I, L.P. 10% owner | Conversion | +938,979 | 1,368,532 | ||
| 2026-08-10 | Westlake BioPartners Fund I, L.P. 10% owner | Conversion | +3,547,842 | 4,916,374 | ||
| 2026-08-10 | Westlake BioPartners Fund I, L.P. 10% owner | Conversion | +1,027,635 | 5,944,009 | ||
| 2026-08-10 | Westlake BioPartners Fund I, L.P. 10% owner | Conversion | +3,464,072 | 3,510,927 | ||
| 2026-08-10 | Westlake BioPartners Fund I, L.P. 10% owner | Conversion | +1,484,401 | 4,995,328 | ||
| 2026-08-10 | Westlake BioPartners Fund I, L.P. 10% owner | Conversion | +165,519 | 5,160,847 | ||
| 2026-08-10 | Westlake BioPartners Fund I, L.P. 10% owner | Conversion | +2,066,857 | 2,094,813 | ||
| 2026-08-10 | Westlake BioPartners Fund I, L.P. 10% owner | Conversion · Series Seed Convertible Preferred Stock | −938,979 | 0 | ||
| 2026-08-10 | Westlake BioPartners Fund I, L.P. 10% owner | Conversion · Series A Convertible Preferred Stock | −3,547,842 | 0 | ||
| 2026-08-10 | Westlake BioPartners Fund I, L.P. 10% owner | Conversion · Series A-2 Convertible Preferred Stock | −1,027,635 | 0 |
Page 1 of 4 · 69 trades